Cancer Stocks - Cancer Stocks to Buy 2015

Home
Stocks to Watch
Top Stocks 2018
Top Penny Stocks 2018
Penny Stocks
Stock Picks
Stock Gainers - Hot Stocks
Stock Losers - Bad Stocks
Best Performing Stocks
2017 IPO's
Stocks 2017
Top Stocks 2017
Top Penny Stocks 2017
Best Marijuana Stocks
Best Oil Stocks
Best Gold Stocks
Best Uranium Stocks
Best China Stocks
Best Coffee Stocks
Cramer Stock Picks
Penny Stocks to Buy
Cheap Stocks 2017
Top 10 Stocks
Top 10 Penny Stocks
Long Term Stocks
Dividend Stocks
How to Day Trade
Stock Trading Rules
Site Map

Cancer Stocks - Best Cancer Stocks 2015

Cancer stocks continue to be on the radar of investors in 2015.  From Cancer Penny Stocks to Regular Cancer Stocks, below is a list of some Top Cancer Drug Stocks to do your research on.  When companies with good cancer drug trials show positive study data, their stocks skyrocket!  See my full list of top biotech stocks on my biotech page.

counter create hit

Top Cancer Stocks 2015 - Right now, the Top Cancer Stock in 2015 is Agios Pharmaceuticals (AGIO).  Agios Pharmaceuticals (AGIO) is up 80% in the last three months and up 380% in the past year heading into 2015.  The company is developing a cancer drug to treat Advanced Acute Myeloid Leukemia, or cancer of the blood.  In a phase 1 trial, 7 out of 14 people responded to the drug with 4 patients having complete remission.  So far, this cancer drug seems to be working but we will receive more data in 2015.

Watch AGIO in 2015 because if their cancer drug data improves, we could be looking at a $150-$180 stock.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its product candidates include AG-221, an oral inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that harbor IDH2 mutations, as well as for the Type II D-2 hydroxyglutaric aciduria treatment; and AG-120, an oral inhibitor of the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations.

Cancer Stocks 2015Oncothyreon Inc (ONTY) - Oncothyreon Inc (ONTY) is a breast cancer stock that has soared over 100% ytd in 2015.  The company was a huge hit at the 2015 ASCO conference and ONTY stock is now hovering around $4 per share.  Oncothyreon reported ONT-380 from other Her2-blocking breast cancer drugs with much success.  More trial are due later this year and into 2016.  ONTY will have resistance up at $4.25 going forward.

Cancer Stocks to Watch 2015:  JUNO TGTX INSY

My Stock Forum
stockstobuy.org
Join Stockstobuy.org Today!